Ask AI
CheckMate 577 OS
CheckMate 577: Final OS Analysis of Adjuvant Nivolumab vs Placebo in Resected Esophageal or Gastroesophageal Junction Cancer After Neoadjuvant Chemoradiotherapy

Released: June 05, 2025

Expiration: December 04, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 05, 2025

Expiration: December 04, 2025